TOSYMRA Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Tosymra, and what generic alternatives are available?
Tosymra is a drug marketed by Tonix Meds and is included in one NDA. There are nine patents protecting this drug.
This drug has one hundred and two patent family members in thirty-three countries.
The generic ingredient in TOSYMRA is sumatriptan. There are twenty-four drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the sumatriptan profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Tosymra
A generic version of TOSYMRA was approved as sumatriptan by LANNETT CO INC on February 19th, 2016.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for TOSYMRA?
- What are the global sales for TOSYMRA?
- What is Average Wholesale Price for TOSYMRA?
Summary for TOSYMRA
International Patents: | 102 |
US Patents: | 9 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 70 |
Patent Applications: | 4,236 |
Drug Prices: | Drug price information for TOSYMRA |
What excipients (inactive ingredients) are in TOSYMRA? | TOSYMRA excipients list |
DailyMed Link: | TOSYMRA at DailyMed |


Pharmacology for TOSYMRA
Drug Class | Serotonin-1b and Serotonin-1d Receptor Agonist |
Mechanism of Action | Serotonin 1b Receptor Agonists Serotonin 1d Receptor Agonists |
US Patents and Regulatory Information for TOSYMRA
TOSYMRA is protected by nine US patents.
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Tonix Meds | TOSYMRA | sumatriptan | SPRAY;NASAL | 210884-001 | Jan 25, 2019 | RX | Yes | Yes | 9,211,282 | ⤷ Try for Free | Y | ⤷ Try for Free | |||
Tonix Meds | TOSYMRA | sumatriptan | SPRAY;NASAL | 210884-001 | Jan 25, 2019 | RX | Yes | Yes | 9,283,280 | ⤷ Try for Free | Y | ⤷ Try for Free | |||
Tonix Meds | TOSYMRA | sumatriptan | SPRAY;NASAL | 210884-001 | Jan 25, 2019 | RX | Yes | Yes | 11,337,962 | ⤷ Try for Free | Y | ⤷ Try for Free | |||
Tonix Meds | TOSYMRA | sumatriptan | SPRAY;NASAL | 210884-001 | Jan 25, 2019 | RX | Yes | Yes | 12,090,139 | ⤷ Try for Free | Y | ⤷ Try for Free | |||
Tonix Meds | TOSYMRA | sumatriptan | SPRAY;NASAL | 210884-001 | Jan 25, 2019 | RX | Yes | Yes | 8,440,631 | ⤷ Try for Free | Y | ⤷ Try for Free | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
EU/EMA Drug Approvals for TOSYMRA
Company | Drugname | Inn | Product Number / Indication | Status | Generic | Biosimilar | Orphan | Marketing Authorisation | Marketing Refusal |
---|---|---|---|---|---|---|---|---|---|
Galpharm Healthcare Ltd. | Sumatriptan Galpharm | sumatriptan | EMEA/H/C/002140 |
Refused | yes | no | no | 2012-02-09 | |
>Company | >Drugname | >Inn | >Product Number / Indication | >Status | >Generic | >Biosimilar | >Orphan | >Marketing Authorisation | >Marketing Refusal |
International Patents for TOSYMRA
See the table below for patents covering TOSYMRA around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Japan | 2021508670 | 疾患の処置のための鼻腔内エピネフリン製剤及び方法 | ⤷ Try for Free |
United Kingdom | 202016960 | ⤷ Try for Free | |
Russian Federation | 2554814 | КОМПОЗИЦИИ ДЛЯ ВВЕДЕНИЯ ЛЕКАРСТВЕННЫХ СРЕДСТВ (COMPOSITIONS FOR DRUG INTRODUCTION) | ⤷ Try for Free |
United Kingdom | 202012086 | ⤷ Try for Free | |
Finland | C20250011 | ⤷ Try for Free | |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for TOSYMRA
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
3678649 | 301317 | Netherlands | ⤷ Try for Free | PRODUCT NAME: COMBINATIE VAN EPINEFRINE OF EEN ZOUT DAARVAN, EN DODECYLMALTOSIDE; REGISTRATION NO/DATE: EU1/24/1846 20240823 |
3678649 | PA2025507 | Lithuania | ⤷ Try for Free | PRODUCT NAME: VISU FORMU EPINEFRINO IR DODECILMALTOZIDO DERINYS SAUGOMASPAGRINDINIO PATENTO; REGISTRATION NO/DATE: EU/1/24/1846 20240822 |
3678649 | 122025000010 | Germany | ⤷ Try for Free | PRODUCT NAME: KOMBINATION AUS EPINEPHRIN AND DODECYLMALTOSID, IN ALLEN DEM SCHUTZ DES GRUNDPATENTS UNTERLIEGENDEN FORMEN; REGISTRATION NO/DATE: EU/1/24/1846 20240822 |
3678649 | C20250011 | Finland | ⤷ Try for Free | |
3678649 | CA 2025 00007 | Denmark | ⤷ Try for Free | PRODUCT NAME: KOMBINATION AF EPINEPHRIN ELLER ET SALT DERAF, OG DODECYLMATOSID; REG. NO/DATE: EU/1/24/1846 20240823 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Market Dynamics and Financial Trajectory for Tosymra®
More… ↓